QuintilesIMS rebrands as IQVIA
DANBURY, Conn., and RESEARCH TRIANGLE PARK, N.C. — Analytics company QuintilesIMS has a new name. Effective Nov. 6, the company will do business as IQVIA, with its name ticker symbol on the New York Stock Exchange set to switch to IQV on Nov. 15. The name change comes almost a year and a half after Quintiles merged with IMS Health in a $9 billion deal.
“Today is a defining moment for our organization as we introduce a new name that aligns with our vision to help stakeholders drive healthcare forward,” IQVIA Chairman and CEO Ari Bousbib said. “Our clients have been instrumental in our becoming IQVIA. IMS Health and Quintiles came together because our clients were asking for better, faster ways to bring innovations to patients and capture the improvements the industry has been pursuing for years.”
IQVIA also announced that its client solutions would be powered by the IQVIA CORE, which it says allows the company to offer customized solutions for its clients using advanced analytics and extensive industry knowledge.
“Since the merger, we’ve worked to integrate our capabilities in advanced analytics, leading technologies and therapeutic expertise into powerful, differentiated offerings,” Bousbib said. “Our vision is to outpace the inevitable progress of change across the life sciences and accelerate our ability to empower healthcare decision makers to meet the future head on.”